DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians

Malyszko, Jolanta; De Seigneux, Sophie; Cantaluppi, Vincenzo; Faguer, Stanislas; Gameiro, Joana; Lopes, Jose Antonio; Sanz Bartolome, Ana; Saritas, Turgay; Selby, Nicholas M.; Ostermann, Marlies

doi:10.1093/ndt/gfaf013

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians

Malyszko, Jolanta; De Seigneux, Sophie; Cantaluppi, Vincenzo; Faguer, Stanislas; Gameiro, Joana; Lopes, Jose Antonio; Sanz Bartolome, Ana; Saritas, Turgay; Selby, Nicholas M.; Ostermann, Marlies

Authors

Jolanta Malyszko

Sophie De Seigneux

Vincenzo Cantaluppi

Stanislas Faguer

Joana Gameiro

Jose Antonio Lopes

Ana Sanz Bartolome

Turgay Saritas

Professor NICHOLAS SELBY Nicholas.Selby@nottingham.ac.uk
PROFESSOR OF NEPHROLOGY

Marlies Ostermann

Citation

Malyszko, J., De Seigneux, S., Cantaluppi, V., Faguer, S., Gameiro, J., Lopes, J. A., Sanz Bartolome, A., Saritas, T., Selby, N. M., & Ostermann, M. (2025). DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians. Nephrology Dialysis Transplantation, https://doi.org/10.1093/ndt/gfaf013

Journal Article Type	Article
Acceptance Date	Jan 13, 2025
Online Publication Date	Jan 15, 2025
Publication Date	Jan 15, 2025
Deposit Date	Jan 23, 2025
Publicly Available Date	Jan 16, 2026
Journal	Nephrology Dialysis Transplantation
Print ISSN	0931-0509
Electronic ISSN	1460-2385
Publisher	Oxford University Press
Peer Reviewed	Peer Reviewed
DOI	https://doi.org/10.1093/ndt/gfaf013
Public URL	https://nottingham-repository.worktribe.com/output/44234312
Publisher URL	https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf013/7954741